Perbedaan Kalbe Farma Tbk dan Multifiling Mitra Indonesia Tbk.: Kalbe Farma Tbk diperdagangkan di Rp735 (kapitalisasi pasar 35,34 T, volume 24 jam 108,3 jt), sedangkan Multifiling Mitra Indonesia Tbk. diperdagangkan di Rp1.300 (kapitalisasi pasar 984,86 M). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 35,9× kapitalisasi pasar Multifiling Mitra Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | MFMI | |
|---|---|---|
Kapitalisasi Pasar | 35,34 T | 984,86 M |
Volume | 108,3 jt | — |
Lot | 1,08 jt | — |
Perputaran | 80,02 M | — |
Harga Rata-rata | 738,89 | — |
Nilai Transaksi | 80,02 M | — |
Harga Ekuilibrium Indikatif | 735 | — |
Volume Ekuilibrium Indikatif | 59,74 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.
Selengkapnya di halaman MFMI →